{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:37:56Z","timestamp":1791275876485,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T00:00:00Z","timestamp":1303948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0019104","type":"journal-article","created":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T17:20:44Z","timestamp":1304011244000},"page":"e19104","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Dendritic Cells Crosspresent Antigens from Live B16 Cells More Efficiently than from Apoptotic Cells and Protect from Melanoma in a Therapeutic Model"],"prefix":"10.1371","volume":"6","author":[{"given":"Diana","family":"Matheoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Baey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Vimeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Tempez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Louche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Le Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hosmalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Feuillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,4,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.0105-2896.2005.00316.x","article-title":"Mechanisms of MHC class I-restricted antigen processing and cross-presentation.","volume":"207","author":"P Cresswell","year":"2005","journal-title":"Immunol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.20.100301.064828","article-title":"Antigen presentation and T cell stimulation by dendritic cells.","volume":"20","author":"P Guermonprez","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","article-title":"Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.","volume":"199","author":"WR Heath","year":"2004","journal-title":"Immunol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger.","volume":"8","author":"H Kono","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2780","article-title":"Cross-priming in health and disease.","volume":"10","author":"C Kurts","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine.","volume":"449","author":"RM Steinman","year":"2007","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0065-230X(07)99006-5","article-title":"Dendritic cells in cancer immunotherapy.","volume":"99","author":"A Vulink","year":"2008","journal-title":"Adv Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.","volume":"2","author":"FJ Hsu","year":"1996","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.183.1.317","article-title":"Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.","volume":"183","author":"P Paglia","year":"1996","journal-title":"J Exp Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/1078-0432.CCR-08-2227","article-title":"Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer.","volume":"15","author":"FM Speetjens","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.183.1.87","article-title":"Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.","volume":"183","author":"L Zitvogel","year":"1996","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.cji.0000211309.90621.8b","article-title":"Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.","volume":"29","author":"AK Palucka","year":"2006","journal-title":"J Immunother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/CJI.0b013e318159f5ba","article-title":"Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.","volume":"31","author":"N Bercovici","year":"2008","journal-title":"J Immunother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00262-005-0078-6","article-title":"Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.","volume":"55","author":"M Salcedo","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.192.11.1535","article-title":"Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.","volume":"192","author":"F Berard","year":"2000","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-03-3505","article-title":"Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.","volume":"64","author":"JS Yu","year":"2004","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.cji.0000171291.72039.e2","article-title":"Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial.","volume":"28","author":"WC Lee","year":"2005","journal-title":"J Immunother"},{"key":"ref18","first-page":"1021","article-title":"A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.","volume":"8","author":"AE Chang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref19","first-page":"4446","article-title":"Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.","volume":"60","author":"L Jenne","year":"2000","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.189.5.753","article-title":"CD4 T cells and their role in antitumor immune responses.","volume":"189","author":"RE Toes","year":"1999","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2004-08-3105","article-title":"Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.","volume":"105","author":"M Schnurr","year":"2005","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s002620050465","article-title":"Immunotherapy of cancer with dendritic-cell-based vaccines.","volume":"46","author":"E Gilboa","year":"1998","journal-title":"Cancer Immunol Immunother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.4049\/jimmunol.171.11.5940","article-title":"Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.","volume":"171","author":"RS Goldszmid","year":"2003","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death.","volume":"13","author":"M Obeid","year":"2007","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.gt.3302633","article-title":"Cancer gene therapy: the power of negative thinking.","volume":"13","author":"MT Lotze","year":"2006","journal-title":"Gene Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death.","volume":"9","author":"DR Green","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.4049\/jimmunol.166.6.3717","article-title":"Dendritic cells acquire antigens from live cells for cross-presentation to CTL.","volume":"166","author":"LA Harshyne","year":"2001","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0304860101","article-title":"Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes.","volume":"101","author":"C Maranon","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1182\/blood-2009-11-255935","article-title":"Cross-presentation by dendritic cells from live cells induces protective immune responses in vivo.","volume":"115","author":"D Matheoud","year":"2010","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose?","volume":"4","author":"E Joly","year":"2003","journal-title":"Nat Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1073\/pnas.0308345101","article-title":"Cellular protein is the source of cross-priming antigen in vivo.","volume":"101","author":"L Shen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1073\/pnas.89.13.6020","article-title":"Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.","volume":"89","author":"J Karttunen","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.1073\/pnas.96.22.12703","article-title":"CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose.","volume":"96","author":"C Kurts","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nri11308","article-title":"Death-defying immunity: do apoptotic cells influence antigen processing and presentation?","volume":"4","author":"ML Albert","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.10605","article-title":"Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A\/MART-1 antigen.","volume":"101","author":"N Labarriere","year":"2002","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/nm1679","article-title":"Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection.","volume":"13","author":"PM Rawson","year":"2007","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/cdd.2009.8","article-title":"Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.","volume":"16","author":"M Uhl","year":"2009","journal-title":"Cell Death Differ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1371\/journal.pbio.0030185","article-title":"Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation.","volume":"3","author":"NE Blachere","year":"2005","journal-title":"PLoS Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4049\/jimmunol.0900861","article-title":"Direct antigen presentation and gap junction mediated cross-presentation during apoptosis.","volume":"183","author":"B Pang","year":"2009","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0019104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T19:05:30Z","timestamp":1539975930000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0019104"}},"subtitle":[],"editor":[{"given":"Jean","family":"Kanellopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,28]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0019104","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,28]]}}}